Insulinics

Diabetes health clinics in Florida targeting the massive chronic disease market. Better insulin resistance management creates meaningful patient and economic impact. The clinics show favorable patient outcomes, strong clinic economics, and favorable payer relationships — using investor capital to profitably scale to new locations.

Insulinics of FL operates a proven clinic model focused on insulin resistance management — the root driver of Type 2 diabetes and a key factor in metabolic syndrome, obesity, and cardiovascular risk. Unlike traditional diabetes management approaches that focus on symptom control, Insulinics targets the underlying insulin sensitivity problem with a structured, outcomes-driven protocol.

The clinics are already generating strong unit economics, with favorable payer relationships that create predictable revenue visibility. Patient outcomes are measurable and compelling. The company is now using investor capital to replicate the model in new geographies, building a multi-location healthcare business with a defensible clinical approach.